Trends in Immunology
Immune complex-mediated tissue injury: a multistep paradigm
Section snippets
Pathophysiological events following intravascular formation of ICs
Human diseases associated with ICs are mainly observed in the context of systemic infection and connective tissue autoimmune disease. Infusion of IgG immune aggregates [4] and intravenous administration of antibody to animals with high antigen load, for example during Cryptococcus neoformans infection 5, 6, have been the standard models for the study of hyperacute changes. Infusion of IgG aggregates produces vascular leakage, circulatory shock, a reduction in blood platelet count and leukocyte
The low-affinity receptors for the Fc region of IgG and the complement system mediate the safe removal of ICs
The first direct evidence of the central role of the FcγR in IC-mediated injury came from pharmacological studies with recombinant soluble forms of the ectodomains of human FcγRIIA generated by the insertion of a termination codon 5′ of sequences encoding the transmembrane domain [8]. Injection of the FcγRIIA ectodomain mixed with anti-ovalbumin IgG in rat skin reduced the size of the macroscopic inflammatory lesion and the perivascular infiltrate of polymorphonuclear leukocytes (PMNs) produced
Pathophysiological changes following perivascular formation of IC
Formation of ICs around microvessels and trapping beneath the basement membrane are the hallmarks of the passive reverse variant of the Arthus reaction [29]. This occurs when antibodies are injected into the skin, joints and the peritoneal cavity, or instilled into the airways. The latter is a prototypical model of the pneumonitis caused by inhalation of environmental antigens in people sensitized by chronic exposure to these antigens. Irrespective of the site of IC formation, there is an early
Endothelium-derived autacoids
The endothelium produces several paracrine mediators with biological functions, namely NO, ceramide and endothelin. Initial reports showed inhibition of IC-mediated hemorrhagic lesions by interfering with the L-arginine pathway leading to the production of NO but recent studies in genetically engineered NOS-2-deficient mice stressed the protective effect of NO against injury as a result of its inhibitory effect on the production of chemokines 45, 46. A plausible interpretation of these
The crossroads of proper tissue repair and organ remodeling
Activation of the coagulation cascade definitely occurs in reverse passive Arthus hypersensitivity [52], although the blatant hemorrhagic lesions observed in many organs have obscured the crucial importance of a fine-tuned activation of the coagulation system for proper tissue repair. Inflammatory cytokines enhance the expression of tissue factor and activate the extrinsic pathway of coagulation. Tissue factor initiates the cascade of clotting factors by forming a complex with clotting factor
Concluding remarks
Studies in experimental models of IC-mediated tissue injury have enabled the translation of experimental findings to clinical medicine (Table 1). These models have focused on the early changes produced after challenge by purified cognate antigens, thereby overlooking both the evolution of acute injury towards late organ remodeling and their integration into the general model of function of the immune system, where the cells usually respond to pathogens that exist as particulate matter [64].
Acknowledgements
This work was supported by grants from the Plan Nacional de Salud y Farmacia (grants no. SAF98/0176 and SAF2001/0506), Red Respira and Red de Enfermedades Cardiovasculares from the Instituto de Salud Carlos III. We thank Y.S. Bakhle for critical review of the manuscript. The authors apologize in advance for omitting important contributions of many colleagues because of citation limits.
References (69)
Inhibition of the vascular actions of IgG aggregates by BN52012, a highly specific antagonist of paf-acether
Immunopharmacology
(1985)Vasoactive side effects of intravenous immunoglobulin preparations in a rat model and their treatment with recombinant platelet-activating factor acetylhydrolase
Blood
(2000)Inflammation in autoimmunity: receptors for IgG revisited
Trends Immunol.
(2001)Opposite regulation of type II and III receptors for immunoglobulin G in mouse glomerular mesangial cells and in the induction of anti-glomerular basement membrane (GBM) nephritis
J. Biol. Chem.
(2002)Cytosolic phospholipase A2α reigns supreme in arthritis and bone resorption
Trends Immunol.
(2004)C3b2–IgG complexes retain dimeric C3 fragments at all levels of inactivation
J. Biol. Chem.
(2003)Release of arachidonic acid by stimulation of opsonic receptors in human monocytes: the FcγR and the complement receptor 3 pathways
J. Biol. Chem.
(2003)Overlapping roles of endothelial selectins and vascular cell adhesion molecule-1 in immune complex-induced leukocyte recruitment in the cremasteric microvasculature
Am. J. Pathol.
(2003)- et al.
A dominant role for mast cell Fc receptors in the Arthus reaction
Immunity
(1996) FcγRIII mediates neutrophil recruitment to immune complexes. A mechanism for neutrophil accumulation in immune-mediated inflammation
Immunity
(2001)